At RejuvaTech, we’ve been crafting pharmaceutical-grade anti-aging compounds since 2015, dedicated to research and clinical trials with a sharp focus on natural, plant-based species. Our intensive research draws from both ongoing and historical studies, as well as the ancient wisdom of cultures that harnessed plant extracts for health, to create powerful anti-aging solutions. We stay at the forefront of scientific discoveries, leveraging cutting-edge modern technology to optimize delivery systems that target the right cells and tissues for maximum health benefits. Our flagship offerings include our patented "Triterpenoid Compositions," which rejuvenate skin, boost collagen production, and protect telomeres to slow cellular aging. We also proudly produce RiboGEN®, blending nicotinamide riboside chloride, resveratrol, glutathione, pterostilbene, spermidine, NAC, and l-theanine to enhance cellular energy, combat oxidative stress, and promote longevity. Additionally, our resveratrol stands alone as a potent compound that reduces inflammation, supports cardiovascular health, and activates sirtuins for anti-aging effects, ensuring our products deliver transformative benefits to the body at a cellular level.

Bret M. Lee, a luminary in chemistry, biology, and health science, has dedicated over four decades to pioneering anti-aging research. As Chief Scientist at RejuvaTech and a key contributor to other top health-focused companies, he has focused on unlocking the secrets of cellular vitality and longevity through rigorous scientific inquiry and innovative, plant-based solutions. With advanced degrees in chemistry and biology, Bret’s expertise in natural products—particularly triterpenoids and other bioactive botanical compounds—has fueled groundbreaking advancements in the field.

His work includes leading the development of pharmaceutical-grade anti-aging compounds for research and clinical trials, as well as securing notable pending patents like "Triterpenoid Compositions and Methods of Delivery" and the "Strategy for the Delivery of Triterpenoids in Skin Cells" for skin applications. At RejuvaTech, Bret has also spearheaded the creation of RiboGEN®, a potent blend of resveratrol, glutathione, pterostilbene, spermidine, NAC, and l-theanine designed to boost cellular energy and promote longevity.

Dr. Santiago T. Peña, Jr. is a distinguished researcher, and academic leader whose pioneering work in biotechnology and health science has positioned him as a vital contributor to advancements in human and animal health. Currently serving as the Vice President for Research, Extension, and Innovation at Visayas State University (VSU) in Baybay City, Leyte, Philippines, Dr. Peña is at the forefront of cutting-edge research initiatives aimed at addressing pressing health challenges in Eastern Visayas (Region 8) and around the world. With a career marked by academic excellence, innovative research, and leadership, he is poised to play a pivotal role in the development of the Eastern Visayas Biotechnology (EV-Biotech) research center, a government-funded initiative designed to propel biotechnology research for human health and sustainable development.

A globally recognized scholar, Dr. Peña further honed his skills as a Fellow of the United States Department of Agriculture (USDA) Faculty Exchange Program at the University of Tennessee, Knoxville, in 2023. This experience enriched his understanding of veterinary curriculum development, advanced research methodologies, and collaborative innovation, which he now applies to his leadership at VSU. His research portfolio is both extensive and impactful, with a focus on biotechnology, heat stress effects on reproductive health, and the development of novel protocols for cryopreservation. His widely cited work, including a study on mitigating heat-induced DNA damage using antioxidant supplements (published in PLoS ONE), underscores his contributions to reproductive science and biotechnology.

Ms. Alice Sun, M.S. Chemistry, M.S. Economics & Management

Alice Sun, M.S., MBA, serves as the Director of Technology Transfer where she masterfully orchestrates the synthesis and delivery of cutting-edge anti-aging solutions through strategic partnerships with leading biochemical companies. With a distinguished career spanning over two decades, Alice combines her expertise in biochemical engineering with a sharp business acumen, helping drive RejuvaTech’s mission to transform plant-based research into pharmaceutical-grade products that redefine vitality and longevity.

Armed with a Master’s in Biochemical Engineering and an MBA, Alice excels in bridging the gap between scientific innovation and commercial success. At RejuvaTech, she spearheads communications with external biochemical firms to synthesize products like the patent-pending "Triterpenoid Compositions and Methods of Delivery" and the patent-pending "Strategy for the Delivery of Triterpenoids," ensuring seamless production from concept to reality. She meticulously vets and sources high-tech companies specializing in nanotechnology and advanced delivery methods, securing partnerships that enhance the efficacy of offerings such as RiboGEN®—a potent blend designed to boost cellular energy and combat oxidative stress. Since joining RejuvaTech in 2018 as a technology consultant, Alice has been pivotal in deploying these innovations, safeguarding intellectual property, and accelerating their path to market.

Alice’s strategic vision and collaborative prowess have forged a network of elite partners, amplifying RejuvaTech’s ability to deliver solutions rooted in nature and powered by modern science. Her leadership ensures that every product, from telomere-protecting triterpenoids to vitality-enhancing formulations, reaches its full potential, empowering individuals worldwide to live healthier, more vibrant lives.